Tag Archives: Raclopride/diagnostic use/pharmacokinetics

Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge

Stokes PRA, Egerton A, Watson B, Reid A, Breen G, Lingford-Hughes A, Nutt DJ, Mehta MA. Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge. Neuroimage. October 2010;52(4):1521-1527. Publication Date October 2010 How Analyze was Used “The ROIs were spatially normalised from standard space to individual space by applying the deformation matrix previously…

Microglial activation correlates with severity in Huntington disease: a clinical and PET study

Pavese N, Gerhard A, Tai YF, Ho AK, Turkheimer F, Barker RA, Brooks DJ, Piccini P. Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology. June 2006;66(11):1638-1643. Publication Date June 2006 How Analyze was Used “The standard object map contained regions defined for hypothalamus, frontal, parietal, temporal, and occipital lobes…